Preeclampsia: state of art and future perspectives. A special focus on possible preventions

References

• Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. 2001. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database of Systematic Reviews 10:CD002252.
   Google Scholar
• Abbasalizadeh S, Abam F, Mirghafourvand M, Abbasalizadeh F, Taghavi S, Hajizadeh K. 2020. Comparing levels of vitamin D, calcium and phosphorus in normotensive pregnant women and pregnant women with preeclampsia. Journal of Obstetrics and Gynaecology 40:1069–1073.
   PubMed Web of Science ®Google Scholar
• ACOG. 2019a. ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia. Obstetrics & Gynecology 133:e1–e25.
   PubMed Web of Science ®Google Scholar
• [ACOG]. 2018. ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy. Obstetrics & Gynecology. 132:e44–e52.
   PubMed Web of Science ®Google Scholar
• [ACOG]. 2019b. ACOG Committee Opinion No. 767: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstetrics & Gynecology 133:e174–e180.
   PubMed Web of Science ®Google Scholar
• Ahrens KA, Silver RM, Mumford SL, Sjaarda LA, Perkins NJ, Wactawski-Wende J, et al. 2016. Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses. Obstetrics and Gynecology 127:689–698.
   PubMed Web of Science ®Google Scholar
• Ali D-S, Shah M, Ali A, Malik MO, Rehman F, Badshah H, et al. 2019. Treatment with metformin and combination of metformin plus pioglitazone on serum levels of IL-6 and IL-8 in polycystic ovary syndrome: a randomized clinical trial. Hormone and Metabolic Research 51:714–722.
   PubMed Web of Science ®Google Scholar
• Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, et al. 2002. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 359:1877–1890.
   PubMed Web of Science ®Google Scholar
• Arce-Sánchez L, Vitale SG, Flores-Robles CM, Godines-Enriquez MS, Noventa M, Urquia-Figueroa CM, et al. 2021. Effect of the cut-off level for thyroid-stimulating hormone on the prevalence of subclinical hypothyroidism among infertile Mexican women. Diagnostics 11:417.
   Web of Science ®Google Scholar
• Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. 2007. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369:1791–1798.
   PubMed Web of Science ®Google Scholar
• Bartsch E, Medcalf KE, Park AL, Ray JG. 2016. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. British Medical Journal (Clinical Research ed.) 353:i1753.
   PubMed Web of Science ®Google Scholar
• Basaran A, Basaran M, Topatan B. 2010. Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis. Obstetrical & Gynecological Survey 65:653–667.
   PubMed Web of Science ®Google Scholar
• Bicocca MJ, Mendez-Figueroa H, Chauhan SP, Sibai BM. 2020. Maternal obesity and the risk of early-onset and late-onset hypertensive disorders of pregnancy. Obstetrics and Gynecology 136:118–127.
   PubMed Web of Science ®Google Scholar
• Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. 2014. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: a WHO secondary analysis. PLOS One 9: e91198.
   PubMed Web of Science ®Google Scholar
• Budak MS, Kahramanoglu I, Vitale SG, Akgol S, Dilek ME, Kartal S, et al. 2019. Maternal abdominal subcutaneous fat thickness as a simple predictor for gestational diabetes mellitus. Journal of Perinatal Medicine 47:605–610.
   PubMed Web of Science ®Google Scholar
• Bujold E, Roberge S, Nicolaides KH. 2014. Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation. Prenatal Diagnosis 34:642–648.
   PubMed Web of Science ®Google Scholar
• Burton GJ, Redman CW, Roberts JM, Moffett A. 2019. Pre-eclampsia: pathophysiology and clinical implications. British Medical Journal (Clinical Research ed.) 366:l2381.
   PubMed Web of Science ®Google Scholar
• Butticè S, Laganà AS, Vitale SG, Netsch C, Tanidir Y, Cantiello F, et al. 2017. Ureteroscopy in pregnant women with complicated colic pain: is there any risk of premature labor? Archivio Italiano di Urologia, Andrologia 89:287–292.
   Web of Science ®Google Scholar
• Carr DB, Epplein M, Johnson CO, Easterling TR, Critchlow CW. 2005. A sister's risk: family history as a predictor of preeclampsia. American Journal of Obstetrics and Gynecology 193:965–972.
   PubMed Web of Science ®Google Scholar
• Chappell LC, Brocklehurst P, Green ME, Hunter R, Hardy P, Juszczak E, et al. 2019. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial. Lancet 394:1181–1190.
   PubMed Web of Science ®Google Scholar
• Chen H, Jiang F, Drzymalski D, Chen W, Feng Y, Miao J, et al. 2019. A novel parameter derived from photoplethysmographic pulse wave to distinguish preeclampsia from non-preeclampsia. Pregnancy Hypertension 15:166–170.
   PubMed Web of Science ®Google Scholar
• Chiofalo B, Laganà AS, Vaiarelli A, La Rosa VL, Rossetti D, Palmara V, et al. 2017. Do miRNAs play a role in fetal growth restriction? A fresh look to a busy corner. BioMed Research International 2017:6073167.
   PubMed Web of Science ®Google Scholar
• Churchill D, Duley L, Thornton JG, Moussa M, Ali HS, Walker KF. 2018. Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks’ gestation. The Cochrane Database of Systematic Reviews 10:CD003106.
   PubMed Web of Science ®Google Scholar
• Cignini P, Laganà AS, Retto A, Vitale SG. 2016. Knotting on heaven's door: 3D color Doppler ultrasound imaging of a true cord knot. Archives of Gynecology and Obstetrics 293:1357–1358.
   PubMed Web of Science ®Google Scholar
• Cignini P, Savasta LM, Gulino FA, Vitale SG, Mangiafico L, Mesoraca A, Giorlandino C. 2016. Predictive value of pregnancy-associated plasma protein-A (PAPP-A) and free beta-hCG on fetal growth restriction: results of a prospective study. Archives of Gynecology and Obstetrics 293:1227–1233.
   PubMed Web of Science ®Google Scholar
• Cnossen JS, Morris RK, ter Riet G, Mol BWJ, van der Post JAM, Coomarasamy A, et al. 2008. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. Canadian Medical Association Journal = Journal de L'Association Medicale Canadienne 178:701–711.
   PubMed Web of Science ®Google Scholar
• Correa PJ, Palmeiro Y, Soto MJ, Ugarte C, Illanes SE. 2016. Etiopathogenesis, prediction, and prevention of preeclampsia. Hypertension in Pregnancy 35:280–294.
   PubMed Web of Science ®Google Scholar
• Cox AG, Marshall SA, Palmer KR, Wallace EM. 2019. Current and emerging pharmacotherapy for emergency management of preeclampsia. Expert Opinion on Pharmacotherapy 20:701–712.
   PubMed Web of Science ®Google Scholar
• Cross J, Werb Z, Fisher S. 1994. Implantation and the placenta: key pieces of the development puzzle. Science 266:1508–1518.
   PubMed Web of Science ®Google Scholar
• Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, et al. 2004. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (The FASTER Trial). American Journal of Obstetrics and Gynecology 191:1446–1451.
   PubMed Web of Science ®Google Scholar
• Duley L, Gülmezoglu AM, Henderson-Smart DJ. 2003. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database of Systematic Reviews 2:CD000025.
   Google Scholar
• Duley L, Henderson-Smart D, Knight M, King J. 2003. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews 1:CD004659.
   Google Scholar
• Duley L, Henderson-Smart DJ, Meher S. 2005. Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database of Systematic Reviews 2005:CD005548.
   Google Scholar
• Easterling T, Mundle S, Bracken H, Parvekar S, Mool S, Magee LA, et al. 2019. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. Lancet 394:1011–1021.
   PubMed Web of Science ®Google Scholar
• El-Qarmalawi AM, Morsy AH, Al-Fadly A, Obeid A, Hashem M. 1995. Labetalol vs. methyldopa in the treatment of pregnancy-induced hypertension. International Journal of Gynecology & Obstetrics 49:125–130.
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Maymon E, Chaemsaithong P, Done B, Pacora P, et al. 2017. The prediction of late-onset preeclampsia: results from a longitudinal proteomics study. PLOS One 12: e0181468.
   PubMed Web of Science ®Google Scholar
• Fedullo AL, Schiattarella A, Morlando M, Raguzzini A, Toti E, De Franciscis P, Peluso I. 2021. Mediterranean diet for the prevention of gestational diabetes in the Covid-19 era: implications of IL-6 in diabesity. International Journal of Molecular Sciences 22:1213.
   PubMed Web of Science ®Google Scholar
• Felicia Sunjaya A, Paulo Sunjaya A. 2019. Evaluation of serum biomarkers and other diagnostic modalities for early diagnosis of preeclampsia. Journal of Family & Reproductive Health 13:56–69.
   PubMedGoogle Scholar
• Fox N, Roman A, Saltzman D, Hourizadeh T, Hastings J, Rebarber A. 2014. Risk factors for preeclampsia in twin pregnancies. American Journal of Perinatology 31:163–166.
   PubMed Web of Science ®Google Scholar
• Fox R, Kitt J, Leeson P, Aye CYL, Lewandowski AJ. 2019. Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring. Journal of Clinical Medicine 8:1625.
   PubMed Web of Science ®Google Scholar
• Galaviz-Hernandez C, Sosa-Macias M, Teran E, Garcia-Ortiz JE, Lazalde-Ramos BP. 2018. Paternal determinants in preeclampsia. Frontiers in Physiology 9:1870.
   PubMed Web of Science ®Google Scholar
• Giannakou K, Evangelou E, Papatheodorou SI. 2018. Genetic and non-genetic risk factors for pre-eclampsia: umbrella review of systematic reviews and meta-analyses of observational studies. Ultrasound in Obstetrics & Gynecology 51:720–730.
   PubMed Web of Science ®Google Scholar
• Gonen R, Shahar R, Grimpel YI, Chefetz I, Sammar M, Meiri H, Gibor Y. 2008. Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study. British Journal of Gynecology 115:1465–1472.
   Web of Science ®Google Scholar
• Gormley M, Ona K, Kapidzic M, Garrido-Gomez T, Zdravkovic T, Fisher SJ. 2017. Preeclampsia: novel insights from global RNA profiling of trophoblast subpopulations. American Journal of Obstetrics and Gynecology 217:200.e1–200.e17.
   PubMed Web of Science ®Google Scholar
• Gui J, Ling Z, Hou X, Fan Y, Xie K, Shen R. 2020. In vitro fertilization is associated with the onset and progression of preeclampsia. Placenta 89:50–57.
   PubMed Web of Science ®Google Scholar
• Guo H, Zhu Y, Wu C, Zhong M, Hu S. 2019. Potential urine biomarkers for gestational hypertension and preeclampsia. Molecular Medicine Reports 19:2463–2470.
   PubMed Web of Science ®Google Scholar
• Hauspurg A, Parry S, Mercer BM, Grobman W, Hatfield T, Silver RM, et al. 2019. Blood pressure trajectory and category and risk of hypertensive disorders of pregnancy in nulliparous women. American Journal of Obstetrics and Gynecology 221:277.e1–277–e8.
   PubMed Web of Science ®Google Scholar
• Hernández-Díaz S, Toh S, Cnattingius S. 2009. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. British Medical Journal (Clinical Research ed.) 338:b2255.
   PubMed Web of Science ®Google Scholar
• Hu J, Li Y, Zhang B, Zheng T, Li J, Peng Y, et al. 2019. Impact of the 2017 ACC/AHA guideline for high blood pressure on evaluating gestational hypertension-associated risks for newborns and mothers. Circulation Research 125:184–194.
   PubMed Web of Science ®Google Scholar
• Hutabarat M, Wibowo N, Huppertz B. 2017. The trophoblast survival capacity in preeclampsia. PLOS One 12: e0186909.
   PubMed Web of Science ®Google Scholar
• Hypertension in Pregnancy. 2013. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstetrics and Gynecology 122:1122–1131.
   PubMed Web of Science ®Google Scholar
• Iacobaeus C, Kahan T, Jörneskog G, Bremme K, Andolf E, Thorsell M. 2018. Pregnancy-associated plasma protein-A is positively correlated with first-trimester skin microvascular reactivity. Ultrasound in Obstetrics and Gynecology 51:361–367.
   PubMed Web of Science ®Google Scholar
• Karadağ C, Akar B, Gönenç G, Aslancan R, Yılmaz N, Çalışkan E. 2020. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation. The Journal of Maternal-Fetal & Neonatal Medicine 33:1934–1939.
   PubMed Web of Science ®Google Scholar
• Kasawara KT, Nascimento SLD, Costa ML, Surita FG, Silva JLPE. 2012. Exercise and physical activity in the prevention of pre-eclampsia: systematic review. Acta Obstetricia et Gynecologica Scandinavica 91:1147–1157.
   PubMed Web of Science ®Google Scholar
• Kozer E, Nikfar S, Costei A, Boskovic R, Nulman I, Koren G. 2002. Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. American Journal of Obstetrics and Gynecology 187:1623–1630.
   PubMed Web of Science ®Google Scholar
• Laganà AS, Giordano D, Loddo S, Zoccali G, Vitale SG, Santamaria A, et al. 2017. Decreased endothelial progenitor cells (EPCs) and increased natural killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis. Archives of Gynecology and Obstetrics 295:867–872.
   PubMed Web of Science ®Google Scholar
• Laganà AS, Vitale SG, Salmeri FM, Triolo O, Ban Frangež H, Vrtačnik-Bokal E, et al. 2017. Unus pro omnibus, omnes pro uno: a novel, evidence-based, unifying theory for the pathogenesis of endometriosis. Medical Hypotheses 103:10–20.
   PubMed Web of Science ®Google Scholar
• Laganà AS, Vitale SG, Sapia F, Valenti G, Corrado F, Padula F, et al. 2018. miRNA expression for early diagnosis of preeclampsia onset: hope or hype? The Journal of Maternal-Fetal & Neonatal Medicine 31:817–821.
   PubMed Web of Science ®Google Scholar
• LeFevre ML. 2014. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine 161:819–826.
   PubMed Web of Science ®Google Scholar
• Li J-Y, Wang P-H, Vitale SG, Chen S-N, Marranzano M, Cianci A, et al. 2019. Pregnancy-induced hypertension is an independent risk factor for meconium aspiration syndrome: a retrospective population based cohort study. Taiwanese Journal of Obstetrics and Gynecology 58:396–400.
   PubMed Web of Science ®Google Scholar
• Lisonkova S, Sabr Y, Mayer C, Young C, Skoll A, Joseph KS. 2014. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstetrics and Gynecology 124:771–781.
   PubMed Web of Science ®Google Scholar
• Lumbers ER, Delforce SJ, Arthurs AL, Pringle KG. 2019. Causes and consequences of the dysregulated maternal renin–angiotensin system in preeclampsia. Frontiers in Endocrinology 10:563.
   PubMed Web of Science ®Google Scholar
• Madazli R, Budak E, Calay Z, Aksu MF. 2000. Correlation between placental bed biopsy findings, vascular cell adhesion molecule and fibronectin levels in pre-eclampsia. British Journal of Gynecology 107:514–518.
   Web of Science ®Google Scholar
• Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. 2003. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. British Medical Journal (Clinical Research ed.) 327:955–960.
   PubMed Web of Science ®Google Scholar
• Magnussen EB, Vatten LJ, Smith GD, Romundstad PR. 2009. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstetrics and Gynecology 114:961–970.
   PubMed Web of Science ®Google Scholar
• Magpie Trial Follow-Up Study Collaborative Group. 2007. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. British Journal of Gynecology 114:300–309.
   Web of Science ®Google Scholar
• Mayrink J, Souza RT, Feitosa FE, Rocha Filho EA, Leite DF, Vettorazzi J, et al. 2019. Incidence and risk factors for preeclampsia in a cohort of healthy nulliparous pregnant women: a nested case-control study. Scientific Reports 9:9517.
   PubMed Web of Science ®Google Scholar
• Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. 2016. Pre-eclampsia. Lancet 387:999–1011.
   PubMed Web of Science ®Google Scholar
• Molvi SN, Mir S, Rana VS, Jabeen F, Malik AR. 2012. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa. Archives of Gynecology and Obstetrics 285:1553–1562.
   PubMed Web of Science ®Google Scholar
• Moore-Maxwell CA, Robboy SJ. 2004. Placental site trophoblastic tumor arising from antecedent molar pregnancy. Gynecologic Oncology 92:708–712.
   PubMed Web of Science ®Google Scholar
• Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. 2011. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Journal of the American College of Cardiology 57:1404–1423.
   PubMed Web of Science ®Google Scholar
• Myatt L, Clifton RG, Roberts JM, Spong CY, Hauth JC, Varner MW, et al. 2012. The utility of uterine artery Doppler velocimetry in prediction of preeclampsia in a low-risk population. Obstetrics and Gynecology 120(4):815–822.
   PubMed Web of Science ®Google Scholar
• Newman MG, Robichaux AG, Stedman CM, Jaekle RK, Fontenot MT, Dotson T, Lewis DF. 2003. Perinatal outcomes in preeclampsia that is complicated by massive proteinuria. American Journal of Obstetrics and Gynecology 188:264–268.
   PubMed Web of Science ®Google Scholar
• Nugent CE, Punch MR, Barr M Jr, LeBlanc L, Johnson MP, Evans MI. 1996. Persistence of partial molar placenta and severe preeclampsia after selective termination in a twin pregnancy. Obstetrics & Gynecology 87:829–831.
   PubMed Web of Science ®Google Scholar
• O’Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, Nicolaides KH. 2016. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation. American Journal of Obstetrics and Gynecology 214:103.e1–103.e12.
   PubMed Web of Science ®Google Scholar
• Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ. 1990. Aggressive or expectant management for patients with severe preeclampsia between 28–34 weeks’ gestation: a randomized controlled trial. Obstetrics and Gynecology 76:1070–1075.
   PubMed Web of Science ®Google Scholar
• Peacock WF, Hilleman DE, Levy PD, Rhoney DH, Varon J. 2012. A systematic review of nicardipine vs labetalol for the management of hypertensive crises. The American Journal of Emergency Medicine 30:981–993.
   PubMed Web of Science ®Google Scholar
• Phelan LK, Brown MA, Davis GK, Mangos G. 2004. A prospective study of the impact of automated dipstick urinalysis on the diagnosis of preeclampsia. Hypertension in Pregnancy 23:135–142.
   PubMed Web of Science ®Google Scholar
• Poon LC, Nicolaides KH. 2014. Early prediction of preeclampsia. Obstetrics and Gynecology International 2014:297397.
   PubMedGoogle Scholar
• Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. 2019. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia: a pragmatic guide for first‐trimester screening and prevention. International Journal of Gynecology & Obstetrics 145:1–33.
   PubMed Web of Science ®Google Scholar
• Pratt A, Da Silva Costa F, Borg AJ, Kalionis B, Keogh R, Murthi P. 2015. Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia. Angiogenesis 18:115–123.
   PubMed Web of Science ®Google Scholar
• Procopciuc LM, Caracostea G, Zaharie G, Stamatian F. 2014. Maternal/newborn VEGF-C936T interaction and its influence on the risk, severity and prognosis of preeclampsia, as well as on the maternal angiogenic profile. The Journal of Maternal-Fetal & Neonatal Medicine 27:1754–1760.
   PubMed Web of Science ®Google Scholar
• Raguema N, Moustadraf S, Bertagnolli M. 2020. Immune and apoptosis mechanisms regulating placental development and vascularization in preeclampsia. Frontiers in Physiology 11:98.
   PubMed Web of Science ®Google Scholar
• Ridder A, Giorgione V, Khalil A, Thilaganathan B. 2019. Preeclampsia: the relationship between uterine artery blood flow and trophoblast function. International Journal of Molecular Sciences 20:3263.
   PubMed Web of Science ®Google Scholar
• Rizzo G, Garzon S, Fichera M, Panella MM, Catena U, Schiattarella A, et al. 2019. Vitamin D and gestational diabetes mellitus: is there a link? Antioxidants 8:511.
   Web of Science ®Google Scholar
• Roberge S, Bujold E, Nicolaides KH. 2018. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. American Journal of Obstetrics and Gynecology 218:287–293.e1.
   PubMed Web of Science ®Google Scholar
• Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. 2017. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. American Journal of Obstetrics and Gynecology 216:110–120.e6.
   PubMed Web of Science ®Google Scholar
• Robillard P-Y, Dekker G, Boukerrou M, Boumahni B, Hulsey T, Scioscia M. 2020a. Gestational weight gain and rate of late-onset preeclampsia: a retrospective analysis on 57 000 singleton pregnancies in Reunion Island. BMJ Open 10: e036549.
   PubMed Web of Science ®Google Scholar
• Robillard P-Y, Dekker G, Chaouat G, Elliot MG, Scioscia M. 2019. High incidence of early onset preeclampsia is probably the rule and not the exception worldwide. 20th anniversary of the reunion workshop. A summary. Journal of Reproductive Immunology 133:30–36.
   PubMed Web of Science ®Google Scholar
• Robillard P-Y, Dekker G, Iacobelli S, Chaouat G. 2016. An essay of reflection: why does preeclampsia exist in humans, and why are there such huge geographical differences in epidemiology? Journal of Reproductive Immunology 114:44–47.
   PubMed Web of Science ®Google Scholar
• Robillard P-Y, Dekker G, Scioscia M, Bonsante F, Iacobelli S, Boukerrou M, Hulsey TC. 2019. Increased BMI has a linear association with late-onset preeclampsia: a population-based study. PLOS One 14: e0223888.
   PubMed Web of Science ®Google Scholar
• Robillard P-Y, Dekker G, Boukerrou M, Boumahni B, Hulsey T, Scioscia M. 2020b. The urgent need to optimize gestational weight in overweight/obese women to lower maternal–fetal morbidities: a retrospective analysis on 59,000 singleton term pregnancies. Archives of Women Health and Care 3:1–9.
   Google Scholar
• Rolnik DL, Nicolaides KH, Poon LC. 2020. Prevention of preeclampsia with aspirin. American Journal of Obstetrics and Gynecology 9378:30873–30875.
   Google Scholar
• Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, et al. 2017. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. The New England Journal of Medicine 377:613–622.
   PubMed Web of Science ®Google Scholar
• Rye K-A, Barter PJ, Cochran BJ. 2016. Apolipoprotein A–I interactions with insulin secretion and production. Current Opinion in Lipidology 27:8–13.
   PubMed Web of Science ®Google Scholar
• Salimi S, Yaghmaei M, Tabatabaei E, Mokhtari M, Naghavi A. 2015. Vascular endothelial growth factor (VEGF)-634G/C polymorphism was associated with severe pre-eclampsia and lower serum VEGF level. The Journal of Obstetrics and Gynaecology Research 41:1877–1883.
   PubMed Web of Science ®Google Scholar
• Salman H, Shah M, Ali A, Aziz A, Vitale SG. 2018. Assessment of relationship of serum neurokinin-B level in the pathophysiology of pre-eclampsia: a case-control study. Advances in Therapy 35:1114–1121.
   PubMed Web of Science ®Google Scholar
• Schiattarella A, Lombardo M, Morlando M, Rizzo G. 2021. The impact of a plant-based diet on gestational diabetes: a review. Antioxidants 10:557.
   Web of Science ®Google Scholar
• Schiattarella A, Riemma G, Sisti G, Savoia F, Rapisarda A, De Franciscis P, Morlando M. 2021. Efficacy of phloroglucinol in shortening the first stage of labor: systematic review and meta-analysis of randomized controlled trials. The Journal of Maternal-Fetal & Neonatal Medicine 2021:1–7.
   Web of Science ®Google Scholar
• Scioscia M, Dekker GA, Chaouat G, Dawonauth L, Dechend R, Goldman-Wohl D, et al. 2019. A top priority in pre-eclampsia research: development of a reliable and inexpensive urinary screening test. The Lancet. Global Health 7:e1312–e1313.
   PubMed Web of Science ®Google Scholar
• Scioscia M, Karumanchi SA, Goldman-Wohl D, Robillard P-Y. 2015. Endothelial dysfunction and metabolic syndrome in preeclampsia: an alternative viewpoint. Journal of Reproductive Immunology 108:42–47.
   PubMed Web of Science ®Google Scholar
• Scioscia M, Noventa M, Cavallin F, Straface G, Pontrelli G, Fattizzi N, et al. 2019. Exploring strengths and limits of urinary d-chiro inositol phosphoglycans (IPG-P) as a screening test for preeclampsia: a systematic review and meta-analysis. Journal of Reproductive Immunology 134–135:21–27.
   PubMed Web of Science ®Google Scholar
• Sibai BM. 2004. Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. American Journal of Obstetrics and Gynecology 190:1520–1526.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Mercer BM, Schiff E, Friedman SA. 1994. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks’ gestation: a randomized controlled trial. American Journal of Obstetrics and Gynecology 171:818–822.
   PubMed Web of Science ®Google Scholar
• Silasi M, Cohen B, Karumanchi SA, Rana S. 2010. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstetrics and Gynecology Clinics of North America 37:239–253.
   PubMed Web of Science ®Google Scholar
• Silva VRS, Soardi FC, Tanaka SCSV, da Silva-Grecco RL, Paschoini MC, Balarin MAS. 2015. Investigation of polymorphisms in pre-eclampsia related genes VEGF and IL1A. Archives of Gynecology and Obstetrics 291:1029–1035.
   PubMed Web of Science ®Google Scholar
• Sisti G. 2019. Maternal outcomes associated with lower range stage 1 hypertension. Obstetrics and Gynecology 133:190.
   PubMed Web of Science ®Google Scholar
• Sisti G, Colombi I. 2019. New blood pressure cut off for preeclampsia definition: 130/80 mmHg. European Journal of Obstetrics, Gynecology, and Reproductive Biology 240:322–324.
   PubMed Web of Science ®Google Scholar
• Sisti G, Schiattarella A, Morlando M, Corwin A. 2021. Timing of delivery and blood pressure cut-off in chronic hypertension during pregnancy: state of art and new proposals. International Journal of Gynaecology and Obstetrics.
   Web of Science ®Google Scholar
• Sisti G, Williams B. 2019. Body of evidence in favor of adopting 130/80 mm Hg as new blood pressure cut-off for all the hypertensive disorders of pregnancy. Medicina 55:703.
   PubMed Web of Science ®Google Scholar
• Skjaerven R, Vatten LJ, Wilcox AJ, Rønning T, Irgens LM, Lie RT. 2005. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. British Medical Journal (Clinical Research ed.) 331:877.
   PubMed Web of Science ®Google Scholar
• Sonnaville CMW, Hukkelhoven CW, Vlemmix F, Groen H, Schutte JM, Mol BW, Pampus MG. 2020. Impact of hypertension and preeclampsia intervention trial at near term-I (HYPITAT-I) on obstetric management and outcome in The Netherlands. Ultrasound in Obstetrics & Gynecology 55:58–67.
   PubMed Web of Science ®Google Scholar
• Sotiriadis A, Hernandez‐Andrade E, da Silva Costa F, Ghi T, Glanc P, Khalil A, et al. 2019. ISUOG practice guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia. Ultrasound in Obstetrics & Gynecology 53:7–22.
   PubMed Web of Science ®Google Scholar
• Sturlese E, Triolo O, Grasso R, Laganà AS, Retto A, Rossetti D, et al. 2017. Thromboembolism prophylaxis in laparoscopic surgery for gynecologic benign diseases. Results of a single center experience in 922 procedures. Annali Italiani di Chirurgia 88:342–347.
   PubMed Web of Science ®Google Scholar
• Sutton ALM, Harper LM, Tita ATN. 2018. Hypertensive disorders in pregnancy. Obstetrics and Gynecology Clinics of North America 45:333–347.
   PubMed Web of Science ®Google Scholar
• Tan MY, Syngelaki A, Poon LC, Rolnik DL, O'Gorman N, Delgado JL, et al. 2018. Screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation. Ultrasound in Obstetrics & Gynecology 52:186–195.
   PubMed Web of Science ®Google Scholar
• Tannetta DS, Dragovic RA, Gardiner C, Redman CW, Sargent IL. 2013. Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin. PLOS One 8: e56754.
   PubMed Web of Science ®Google Scholar
• Torella M, Bellini G, Punzo F, Argenziano M, Schiattarella A, Labriola D, et al. 2019. TNF-α effect on human delivery onset by CB1/TRPV1 crosstalk: new insights into endocannabinoid molecular signaling in preterm vs. term labor. Analysis of the EC/EV pathway and predictive biomarkers for early diagnosis of preterm delivery. Minerva Ginecologica 71:359–364.
   PubMed Web of Science ®Google Scholar
• Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM. 2013. The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Pregnancy Hypertension 3:44–47.
   PubMed Web of Science ®Google Scholar
• Vaka VR, Cunningham MW, Deer E, Franks M, Ibrahim T, Amaral LM, et al. 2020. Blockade of endogenous angiotensin II type I receptor agonistic autoantibody activity improves mitochondrial reactive oxygen species and hypertension in a rat model of preeclampsia. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 318:R256–R262.
   PubMed Web of Science ®Google Scholar
• Vetvicka V, Laganà AS, Salmeri FM, Triolo O, Palmara VI, Vitale SG, et al. 2016. Regulation of apoptotic pathways during endometriosis: from the molecular basis to the future perspectives. Archives of Gynecology and Obstetrics 294:897–904.
   PubMed Web of Science ®Google Scholar
• Vijgen SMC, Koopmans CM, Opmeer BC, Groen H, Bijlenga D, Aarnoudse JG, et al. 2010. An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial). British Journal of Gynecology 117:1577–1585.
   Web of Science ®Google Scholar
• Villa PM, Marttinen P, Gillberg J, Lokki AI, Majander K, Ordén M-R, et al. 2017. Cluster analysis to estimate the risk of preeclampsia in the high-risk Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study. PLOS One 12:e0174399.
   PubMed Web of Science ®Google Scholar
• Vitale SG, Capriglione S, Peterlunger I, La Rosa VL, Vitagliano A, Noventa M, et al. 2018. The role of oxidative stress and membrane transport systems during endometriosis: a fresh look at a busy corner. Oxidative Medicine and Cellular Longevity 2018:7924021.
   PubMed Web of Science ®Google Scholar
• Vitale SG, Corrado F, Caruso S, Di Benedetto A, Giunta L, Cianci A, D'Anna R. 2021. Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes – a randomized and open-label, placebo-controlled clinical trial. International Journal of Food Sciences and Nutrition 72:670–679.
   PubMed Web of Science ®Google Scholar
• Vitale SG, Fiore M, La Rosa VL, Rapisarda AMC, Mazza G, Paratore M, et al. 2022. Liposomal ferric pyrophosphate and ascorbic acid supplementation in pregnant women with iron deficiency anaemia: haematochemical, obstetric, neonatal and psychological outcomes in a prospective observational study. International Journal of Food Sciences and Nutrition 73:221–229.
   PubMed Web of Science ®Google Scholar
• Vitale SG, Marilli I, Rapisarda AM, Iapichino V, Stancanelli F, Cianci A. 2015. Diagnosis, antenatal surveillance and management of prolonged pregnancy: current perspectives. Minerva Ginecologica 67:365–373.
   PubMedGoogle Scholar
• Vitale SG, Marilli I, Rapisarda AM, Rossetti D, Belluomo G, Iapichino V, et al. 2014. Cellular and biochemical mechanisms, risk factors and management of preterm birth: state of the art. Minerva Ginecologica 66:589–595.
   PubMedGoogle Scholar
• Wang J, Dong X, Wu H, Wu N, Zhang X, Wang X, Shang L. 2016. Relationship of liver X receptors α and endoglin levels in serum and placenta with preeclampsia. PLOS One 11:e0163742.
   PubMed Web of Science ®Google Scholar
• Watanabe N, Fujiwara T, Suzuki T, Jwa SC, Taniguchi K, Yamanobe Y, et al. 2014. Is in vitro fertilization associated with preeclampsia? A propensity score matched study. BMC Pregnancy and Childbirth 14:69.
   PubMed Web of Science ®Google Scholar
• Witcher PM. 2018. Preeclampsia: acute complications and management priorities. AACN Advanced Critical Care 29:316–326.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2011. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia [online]. Available from: http://apps.who.int/iris/bitstream/10665/44703/1/9789241548335_eng.pdf
   Google Scholar
• World Health Organization. 2013. Guideline: calcium supplementation in pregnant women. https://apps.who.int/iris/handle/10665/85120
   Google Scholar
• Wright D, Nicolaides KH. 2019. Aspirin delays the development of preeclampsia. American Journal of Obstetrics and Gynecology 220:580.e1–580.e6.
   PubMed Web of Science ®Google Scholar
• Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH. 2015. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. American Journal of Obstetrics and Gynecology 213:62.e1–62.e10.
   PubMed Web of Science ®Google Scholar
• Wyatt-Ashmead J. 2011. Antenatal closure of the ductus arteriosus and hydrops fetalis. Pediatric and Developmental Pathology 14:469–474.
   PubMed Web of Science ®Google Scholar
• Zeisler H, Llurba E, Chantraine FJ, Vatish M, Staff AC, Sennström M, et al. 2019. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting. Ultrasound in Obstetrics & Gynecology 53:367–375.
   PubMed Web of Science ®Google Scholar
• Zhang P. 2021. Phenotypic switch of endovascular trophoblasts in decidual vasculopathy with implication for preeclampsia and other pregnancy complications. Fetal and Pediatric Pathology 40:543–520.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Damsky CH, Fisher SJ. 1997. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? The Journal of Clinical Investigation 99:2152–2164.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Gormley MJ, Hunkapiller NM, Kapidzic M, Stolyarov Y, Feng V, et al. 2013. Reversal of gene dysregulation in cultured cytotrophoblasts reveals possible causes of preeclampsia. The Journal of Clinical Investigation 123:2862–2872.
   PubMed Web of Science ®Google Scholar